reach candidate list

REACH Candidate List: A Complete Guide for 2026

Par Fritz 14 min de lecture
reach candidate list svhc compliance echa reach regulation scip database

A customer email lands in your inbox before 9 a.m. They want confirmation that none of the articles you supply contain newly listed SVHCs. Procurement is asking for a declaration template. Product stewardship wants to know whether any SDSs need review. Your suppliers are slow to answer, and management wants a clear risk statement by the end of the day.

That's the moment the REACH Candidate List stops being a legal abstraction and becomes an operational problem.

For manufacturers, importers, and distributors in the EU, the hard part usually isn't understanding that the list exists. It's building a working process around it. You need to know what the list means, what changes when it updates, where the legal triggers sit, and how to move from substance identification to supply chain action without scrambling every time ECHA publishes an update.

What Is the REACH Candidate List

The REACH Candidate List is best understood as a regulatory watch list for substances that regulators consider especially concerning. It is not the final stage of control, but it is the stage where companies need to start acting as if future pressure is likely.

Under Article 59(10), the list identifies Substances of Very High Concern (SVHCs). These include substances added because they are carcinogenic, mutagenic, or toxic for reproduction (CMR), persistent, bioaccumulative and toxic (PBT), or because they raise equivalent concern, such as endocrine disruption. As of February 2026, the list contains 253 substances and is dynamically updated, which is why companies need continuous monitoring, as outlined in QPoint Tech's explanation of the Candidate List and related REACH lists.

An infographic titled Understanding the REACH Candidate List explaining SVHCs, why to monitor them, and affected businesses.

Why the list matters in practice

A lot of teams treat the Candidate List as a reference file they consult only when a customer asks a question. That approach usually fails. The list is a trigger point for disclosure, downstream communication, internal product review, and in some cases a broader redesign of sourcing and formulation decisions.

The more useful mental model is this: the Candidate List is where a substance moves from ordinary regulatory background noise into active commercial risk. Customers start screening for it. Procurement teams start asking for declarations. Auditors and enforcement authorities expect you to know whether it appears in your products.

You can browse a practical overview of the substance of very high concern list through ReachLex's SVHC list resource, but the key business point is simpler than the legal language. Once a substance lands on this list, waiting for a later restriction or authorisation decision is usually too late.

Practical rule: If a substance is on the Candidate List, treat it as a present disclosure issue and a future substitution issue.

The gateway to stricter controls

The Candidate List also matters because it is the gateway to the Authorisation List under Annex XIV. In other words, Candidate List inclusion is often the point where regulatory scrutiny starts to harden into strategic business consequences.

As of November 2024, the REACH Candidate List contained 242 substances, and that number had grown steadily since ECHA first published the inaugural list in 2008, according to Z2Data's REACH overview. That steady expansion tells you something important. This is not a static register. It is an active mechanism that pushes industry to identify, disclose, and in many cases replace substances before market access becomes more difficult.

If your company sells into the EU, the question isn't whether the REACH Candidate List is relevant. The question is whether your internal process is good enough to keep pace with it.

How Substances Are Added to the List

The list doesn't grow randomly. New entries follow a formal path, and once you understand that path, updates become easier to anticipate. That matters because good compliance managers don't just react to published additions. They watch the pipeline before a final listing appears.

An infographic showing the four-step process for adding substances to the REACH SVHC Candidate List.

The path from concern to listing

A substance is typically proposed for SVHC identification by an EU Member State or by ECHA acting at the request of the European Commission. The proposal is built into a formal dossier that argues why the substance meets one of the legal SVHC criteria.

That process matters because companies often act as though a Candidate List update is sudden. It usually isn't. By the time the final inclusion happens, the substance has already moved through a visible regulatory process.

A useful place to understand that dossier stage is ReachLex's overview of Annex XV dossiers, because that's where many compliance teams can start spotting future relevance earlier than they would from the final Candidate List alone.

Consultation and decision

After proposal, the substance goes through public consultation. Industry, NGOs, and other stakeholders can submit comments and supporting information. In practice, this is often the only meaningful chance for companies to put use patterns, exposure context, and alternatives information into the record before the substance is formally identified.

Then ECHA's Member State Committee reviews the proposal and comments. If the committee agrees, the substance is identified as an SVHC and included in the Candidate List.

A company that starts reviewing a substance only after formal inclusion is usually working with less time, weaker supplier leverage, and fewer substitution options.

What this means for compliance planning

For a busy regulatory team, the operational lesson is straightforward:

  • Watch proposals early: Don't wait for a final list update if a substance is commercially important to your portfolio.
  • Map product exposure: If a proposed substance appears in raw materials, mixtures, or article components, flag those products before listing.
  • Prepare internal owners: Procurement, product stewardship, and commercial teams should know which substances could trigger customer questions next.

The point isn't to overreact to every proposal. It's to separate noise from relevance. If a substance has no place in your business, note it and move on. If it sits in a key coating, polymer additive, adhesive, or imported component, the smart move is to assess early while your options are still broader.

Many companies make a common error: they know a substance was added to the Candidate List, but they don't translate that event into concrete actions by product type, concentration, and annual volume. Legal compliance under REACH is not satisfied by general awareness.

A professional woman in a suit using a magnifying glass to review legal compliance documentation.

Article 33 communication duty

If an SVHC exceeds 0.1% w/w in an article, the supplier must provide sufficient information to allow safe use of that article. That trigger is not optional and it applies once the substance is on the Candidate List, as summarized in Compliance Gate's explanation of REACH SVHC obligations.

For most businesses, this means your article compliance file needs more than a broad supplier assurance. You need a defensible basis for saying whether the threshold is exceeded. Depending on the complexity of the product, that may involve bill of materials analysis, material declarations, and targeted testing.

For the legal framework behind supply chain information duties, ReachLex's Title IV resource on information in the supply chain is a useful reference point when you need to align internal procedures with REACH text.

SCIP notification

A listed SVHC in an article doesn't only create a customer communication issue. The Candidate List also feeds into SCIP obligations under the waste information regime. If you place relevant articles on the market, you need to determine whether SCIP submission is required and whether your internal product data supports it.

Weak data structures become expensive. Companies that manage composition data in scattered spreadsheets usually struggle here. Teams with structured article-level data move much faster.

Don't treat SCIP as a separate project. Treat it as an output of the same substance intelligence process you use for Article 33.

ECHA notification duty

There is a second threshold to watch. If an article contains an SVHC above 0.1% w/w and the total amount of that SVHC in articles exceeds 1 ton per year, a notification to ECHA is required, according to Z2Data's REACH notification explainer.

That dual trigger catches companies off guard because they focus only on concentration and forget annual aggregate quantity. A single low-volume product line may not create a notification obligation. A broad portfolio with repeated use of the same SVHC in imported articles might.

Registration and verification realities

Separate from Candidate List communication and article notification rules, any manufacturer or importer producing or importing more than one metric ton per year of a substance must register it with ECHA under REACH, as noted in Spacegoats' summary of REACH compliance basics. That obligation sits in a different part of the REACH system, but in practice your substance inventory work often overlaps.

A point many businesses resist at first is verification. Supplier self-declarations have value, but they are not always enough for regulatory assurance. Compliance often requires third-party laboratory testing, especially where the supply chain is opaque or the formulation risk is high, as noted in the earlier Compliance Gate reference.

What works and what doesn't

A simple comparison usually makes the difference clear:

Approach What happens in practice
Generic supplier statement Fast to collect, weak when substance identity or concentration is unclear
Full material declaration Better for threshold analysis and customer response
Targeted laboratory testing Useful where declarations are incomplete, inconsistent, or unreliable
Ad hoc email chasing after each update Creates delays, duplicate work, and inconsistent records

The strongest systems combine supplier declarations, internal composition review, and testing where the risk justifies it. The weakest systems rely on annual questionnaires and hope the answers remain valid after every Candidate List update.

Practical Steps for Candidate List Compliance

The companies that handle the REACH Candidate List well don't improvise. They run a repeatable workflow. That workflow doesn't need to be complicated, but it does need owners, records, and trigger points.

Build a standing workflow

Start with a permanent monitoring routine. The list changes over time, so your process can't depend on someone noticing an update by chance. Assign ownership to one function, usually Regulatory Affairs or Product Stewardship, and define what happens when a new listing appears.

Then connect that trigger to your product data. If the monitoring step isn't linked to BOM review, supplier outreach, and legal assessment, you still have awareness without control.

A practical workflow usually looks like this:

  1. Monitor the list update
  2. Screen substances against portfolio data
  3. Request or refresh supplier declarations
  4. Assess concentration in each relevant article
  5. Decide on communication, SCIP, and ECHA actions
  6. Record the outcome and retain evidence

Focus on data quality first

Most failures happen before legal interpretation. They happen because the company doesn't fully know what is in the product at a level precise enough to assess Candidate List relevance.

Use supplier declarations that identify substances clearly by substance name, CAS, or EC number where possible. Ask for concentration information or at least threshold-based confirmation tied to the updated list, not a generic “REACH compliant” statement. That phrase is too vague to support a real decision.

A declaration that says “compliant with REACH” tells you almost nothing about Article 33 duties.

Practical actions that save time later

  • Set a product triage order: Review high-volume, high-risk, and customer-sensitive products first. Don't start with the easiest file in the drawer.
  • Separate substances, mixtures, and articles: The legal questions differ. Your internal checklist should too.
  • Escalate non-responsive suppliers early: If a supplier won't confirm composition, don't leave the item in an informal pending folder. Give it a risk status and involve procurement.
  • Keep evidence with the decision: Store declarations, test reports, calculations, and customer communications together so your team can defend the conclusion later.

Treat calculations as decision records

Threshold assessment needs a clear method. If a substance appears in a component, someone should be able to reconstruct how your team concluded whether the article exceeded the legal threshold. That reconstruction matters during audits, customer inquiries, and internal reviews after a list update.

Many teams get stuck because they chase perfect data when they really need decision-ready data. If the supplier can confirm the article exceeds the threshold, move directly to disclosure duties. If they can't confirm and the material profile suggests plausible presence, classify the item as unresolved risk and decide whether testing or temporary commercial restriction is the safer path.

Don't centralize everything in one person

One experienced compliance manager can coordinate the process. That doesn't mean one person should carry it alone. Candidate List compliance works best when responsibilities are split clearly:

  • Regulatory interprets the trigger.
  • Procurement obtains supplier evidence.
  • Product teams confirm article structure.
  • Quality or EHS supports verification.
  • Sales receives approved communication language.

That division prevents the familiar bottleneck where every customer request, supplier chase, and legal interpretation lands on a single desk.

How to Search and Monitor the List Effectively

Manual monitoring is possible. For a small portfolio, it may even seem manageable at first. The trouble starts when your product range grows, suppliers use inconsistent substance naming, and customer deadlines don't leave room for repeated manual checking.

Manual monitoring on official sources

The official route is to review ECHA's published Candidate List updates and compare the newly listed substances against your own material and article data. That sounds simple. In practice, it means checking names, CAS numbers, EC numbers, synonyms, and sometimes functional descriptions across declarations that were never designed for clean searching.

Teams often discover the same three problems quickly:

Manual method Common weakness
Checking one substance at a time Slow and vulnerable to missed synonyms
Reviewing PDF declarations manually Hard to search consistently across suppliers
Relying on memory or inbox folders No audit trail and no reliable re-check cycle

The manual route can still work for highly disciplined teams with limited product complexity. But it doesn't scale well, and it creates avoidable human error.

What efficient monitoring looks like

An efficient process has three characteristics. It is searchable, repeatable, and easy to hand over. If your process depends on one specialist remembering which spreadsheet version is current, it isn't stable enough.

A dedicated regulatory platform changes the workload. Instead of checking each substance against disconnected files, your team can search by CAS, EC number, or substance name in one place and screen documents at speed.

The screenshot below shows the kind of search environment that reduces manual review effort:

Screenshot from https://reachlex.eu

A better monitoring routine

If you're building a practical operating model, use this comparison:

  • Manual checking works when your portfolio is narrow, supplier data is strong, and updates affect only a small number of products.
  • Automated or platform-supported checking works better when you handle multilingual documents, broad article portfolios, and repeated customer declaration requests.

The biggest gain isn't just speed. It's consistency. A proper system lets different team members arrive at the same result using the same search logic and the same current regulatory text.

Fast compliance is useful. Defensible compliance is what actually protects the business.

What to monitor besides the final list

Smart monitoring also includes upstream signals. If you only watch the final Candidate List publication, you're choosing the latest possible moment to act. Monitoring related dossiers, substance identities under review, and recurring supplier exposures puts you in a stronger position with procurement and provides more time for technical assessment.

That's especially important when your product relies on specialized additives or imported components. In those situations, a customer question can arrive before your supplier has updated its own declarations. A well-structured monitoring system gives you a way to answer with evidence instead of hesitation.

Beyond Compliance Strategic Supply Chain Management

The strongest companies don't treat the REACH Candidate List as a periodic paperwork exercise. They use it as an early warning system for sourcing, formulation, and customer strategy.

A listed substance is telling you something before any later control measure arrives. It is telling you which parts of your portfolio may become harder to justify, harder to buy, or harder to sell.

Use the information window

Most guidance stops at the 0.1% communication threshold. That's necessary, but it's not enough. The more useful move is to use the information window after Candidate List inclusion to assess alternatives and reduce future disruption. As ChemSafetyPro notes in its discussion of Candidate List growth and risk mitigation, organizations can use this period to find safer alternatives before restrictions are imposed, which turns regulatory data into a competitive advantage.

That's exactly how mature regulatory teams work. They don't ask only, “Do we need to disclose this?” They ask, “If this substance becomes commercially toxic in the market, what is our replacement path?”

Where strategic value shows up

The value usually appears in three places:

  • Product design: R&D can prioritize SVHC-free formulations in products that matter most to future revenue.
  • Procurement advantage: Buyers can push suppliers for substitute materials before the whole market starts asking at once.
  • Customer trust: Commercial teams can answer substance questions with clarity and, where relevant, with a substitution roadmap.

A practical decision filter

Not every listed substance justifies an urgent redesign project. Use a filter that asks:

  1. Is the substance present in revenue-critical products?
  2. Is it difficult to replace technically?
  3. Does it sit in a supply chain with weak transparency?
  4. Are key customers already asking for SVHC-free status?

If the answer is yes to several of those, don't park the issue in a compliance register. Put it into business planning.

The Candidate List is not only a disclosure trigger. It is market intelligence about where future pressure is likely to land.

What reactive companies miss

Reactive companies often stay legally compliant and still lose ground. They disclose on time, but they don't prepare for customer phase-out policies, longer sourcing cycles, or product redesign deadlines. By the time the market starts preferring alternatives, they are negotiating from a weaker position.

Proactive companies use Candidate List signals to redesign before urgency forces them into rushed substitutions. That usually leads to better technical choices, smoother customer communication, and fewer surprises in the supply chain.

FAQ Navigating Common Candidate List Challenges

How does the UK REACH Candidate List affect EU exporters and importers

This is one of the most common practical problems. Companies assume an EU Candidate List update will automatically create the same obligation in the UK, or vice versa. That assumption is risky.

As ACTA Group notes in its discussion of EU and UK Candidate List divergence, companies trading in both markets face uncertainty about whether an EU addition automatically triggers UK obligations, and that requires specific operational adjustments for cross-border trade. In practical terms, you need separate monitoring logic for EU REACH and UK REACH, even if the lists may move closer over time.

The operational fix is straightforward. Keep separate jurisdiction tags in your compliance records, separate declaration templates where needed, and a documented rule for which market triggers which customer communication.

What if a supplier refuses to provide substance information

Treat that as a risk issue, not a procurement inconvenience. If the supplier can't or won't provide enough information for Candidate List assessment, you have three options. Escalate commercially, verify through testing, or restrict use until the data gap is resolved.

What doesn't work is informal tolerance. If a supplier remains opaque and the article is relevant to EU market access, your business is carrying the supplier's compliance risk.

How do you handle complex articles with many components

Break the article into assessable units and work from the highest-risk materials first. Coatings, flame retardant applications, plastic additives, adhesives, and soft components often deserve earlier scrutiny than low-risk metal parts.

For complex products, use a staged method:

  • Stage one: Identify suppliers and components with known low transparency.
  • Stage two: Gather declarations and map probable substance hotspots.
  • Stage three: Calculate threshold relevance or send high-risk components for verification.

This avoids the common mistake of trying to solve every component in full detail before making any practical decision.

Is self-declaration enough

Sometimes it's a starting point. It is not always enough for assurance. If the supply chain is long, the declaration is vague, or the commercial exposure is high, testing and deeper documentation are often the safer path.

What should be in your internal escalation rule

Keep it simple and written down. Escalate when:

  • The supplier data is incomplete
  • A substance match is plausible but unconfirmed
  • A threshold calculation cannot be defended
  • A key customer asks for evidence beyond a simple declaration

That rule prevents endless informal discussions and gives Regulatory Affairs a clear path to action.


If your team needs a faster way to search substances, review multilingual regulatory texts, and screen documents for regulated chemicals, ReachLex is worth a close look. It gives compliance, EHS, legal, and procurement teams one place to check substance obligations across REACH and related EU rules, which makes Candidate List monitoring far easier to manage in day-to-day operations.

Screen documents for chemicals